Sign up to save your podcasts
Or
Share Endocrinology
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Endocrinology
By ReachMDMedicine
Endocrinology episodes
- More Screening Recommendations? These Could Save Your Patient's LifeGuest: Tessa Janovsky, PA-C
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - M3: Managing the Cardiometabolic Risk in MASHGuest: Robert H. Eckel, MD, FAHA, FACC, FNLAGuest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - It All Starts With a PatientGuest: Jeff McIntyre
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
4 min - Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
5 min - I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant FibrosisGuest: Naim Alkhouri, MD, FAASLD, DABOMGuest: Tessa Janovsky, PA-C
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - Treating Patients With T2D and MASLD: Is the Tide Changing?Guest: Naim Alkhouri, MD, FAASLD, DABOM
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?Guest: Robert H. Eckel, MD, FAHA, FACC, FNLA
This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
6 min - ACC 2024: VOYAGER PAD Part 1Host: Marc P. Bonaca, MD, MPH
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
6 min - ACC 2024: SHASTA-2 Final Study ResultsHost: Daniel Gaudet, MD, PhD
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
6 min